Problem device bypassed trials
550945
The catheter that triggered three safety recalls by Boston Scientific Corp. of its best-selling Taxus coronary stent after being linked to three deaths and 47 injuries had not been subjected to the rigors of a human clinical trial, FDA records show.
516340
Yesterday we reported that the Senate Judiciary Committee would be taking up the Induce Act once again. They did so this morning, and the bill failed to advance because of strong opposition from the technology
365018
Internet telephony application balks on IPaq and Axim Pocket PC devices.
483014
Blog: Stripped-down laptop, which was supposed to launch this week, needs a little more time after the discovery of some glitches.
678626
A cheap generic version of blood thinner Plavix, which is used by 48 million Americans, has been blocked by a judge because of a patent dispute just three weeks after it launched.
413577
Â· Motorist denied fitting laser-busting device Â· Businessman is 'first to be convicted' over equipment.
126978
The company announces trial results that, once again, do not meet primary end points.
112205
Software update patches bug in wireless drivers that left systems vulnerable.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
452114
By Anthony Spangler, Fort Worth Star-Telegram, Texas  Sep. 5--A backlog in evidence-testing is creating delays throughout the criminal justice system, leaving prosecutors and local law enforcement authorities struggling to bring some cases to trial.
496826
A software problem delayed the process, which was supposed to start before midnight Eastern time on Wednesday.
631698
An error during routine system testing of United's computer system was the preliminary root cause of yesterday's Computer failure.
688076
Because of PfizerÂs failed trial, drugs similar to torcetrapib from other companies could face greater scrutiny Â and delays Â in getting to market.
706106
By Linda Loyd, The Philadelphia Inquirer  Dec. 7--Auxilium Pharmaceuticals Inc. said it has temporarily suspended a late-stage clinical trial of its injectable drug, AA4500, for Dupuytren's disease, a rare finger joint condition, to investigate a manufacturing issue.
116625
In the digital age, there are few black-and-white rules. Rather, we live in an era of gray when it comes to technology and the law.  A federal case that was recently dismissed before it reached trial is the latest example.
220173
After months of hearings, Microsoft loses EU court battle and must strip Media Player, share code. Also: Federal judge refuses spammer's guilty plea.... Mobile companies dispute evidence that phone radiation damages DNA.... and more.
235475
The outcome of a clinical trial that failed to show Zetia has any benefits adds to concerns over the drug.